OptimizeRx Corporation and Simulmedia Announce Strategic Partnership to Transform Healthcare Advertising with Precision Targeting on TV and Streaming Platforms

Reuters
2025/06/18
<a href="https://laohu8.com/S/OPRX">OptimizeRx Corporation</a> and Simulmedia Announce Strategic Partnership to Transform Healthcare Advertising with Precision Targeting on TV and Streaming Platforms

Simulmedia, a leader in data-driven TV and streaming advertising, has announced a strategic partnership with OptimizeRx Corporation, a prominent provider of healthcare technology solutions. This collaboration introduces the availability of Micro-Neighborhood® Targeting (MNT) audiences across linear, digital, and connected TV channels. The partnership enables healthcare brands, particularly small and mid-size pharmaceutical companies, to activate precise audiences through guaranteed premium TV and streaming inventory with programmatic advertising speed and flexibility. The collaboration addresses industry challenges in linear TV media buying, offering rapid deployment of data-driven campaigns, real-time adjustments, and predictive spot-level placements. This strategic alliance aims to transform how healthcare marketers engage patients and providers throughout the care journey.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250618159849) on June 18, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10